These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2565128)

  • 1. Sulphasalazine in rheumatoid arthritis: haematological problems and changes in haematological indices associated with therapy.
    Farr M; Tunn EJ; Symmons DP; Scott DG; Bacon PA
    Br J Rheumatol; 1989 Apr; 28(2):134-8. PubMed ID: 2565128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematological side-effects of sulphasalazine in inflammatory arthritis.
    Hopkinson ND; Saiz Garcia F; Gumpel JM
    Br J Rheumatol; 1989 Oct; 28(5):414-7. PubMed ID: 2571387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy.
    Amos RS; Bax DE
    Br J Rheumatol; 1988 Dec; 27(6):465-8. PubMed ID: 2904830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.
    Farr M; Tunn E; Crockson AP; Bacon PA
    Clin Rheumatol; 1984 Dec; 3(4):473-81. PubMed ID: 6151882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study.
    Donovan S; Hawley S; MacCarthy J; Scott DL
    Br J Rheumatol; 1990 Jun; 29(3):201-4. PubMed ID: 1972633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
    Chakravarty K; Scott DG; McCann BG
    Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenia in patients with inflammatory arthritis treated with sulphasalazine.
    Farr M; Symmons DP; Blake DR; Bacon PA
    Ann Rheum Dis; 1986 Sep; 45(9):761-4. PubMed ID: 2876683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of acetylator status on sulphasalazine efficacy and toxicity in patients with rheumatoid arthritis.
    Kitas GD; Farr M; Waterhouse L; Bacon PA
    Scand J Rheumatol; 1992; 21(5):220-5. PubMed ID: 1359635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
    Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
    van Riel PL; van Gestel AM; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulphasalazine in rheumatoid arthritis.
    McConkey B; Amos RS; Durham S; Forster PJ; Hubball S; Walsh L
    Br Med J; 1980 Feb; 280(6212):442-4. PubMed ID: 6102877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutropenia in patients with rheumatoid arthritis, treated with sulphasalazine.
    Marouf ES; Morris IM
    Br J Rheumatol; 1990 Oct; 29(5):407-9. PubMed ID: 1977490
    [No Abstract]   [Full Text] [Related]  

  • 14. Felty's syndrome without concomitant arthritis: a variant.
    Cycowitz Z; Heller I; Burke M; Vardinon N; Yust I
    Clin Exp Rheumatol; 1989; 7(3):301-3. PubMed ID: 2758710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiencies associated with sulphasalazine therapy in inflammatory arthritis.
    Farr M; Kitas GD; Tunn EJ; Bacon PA
    Br J Rheumatol; 1991 Dec; 30(6):413-7. PubMed ID: 1684124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the blood picture in sulfasalazine therapy of rheumatoid arthritis].
    Rave O
    Z Rheumatol; 1987; 46(2):86-91. PubMed ID: 2885991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components.
    Dougados M; Combe B; Cantagrel A; Goupille P; Olive P; Schattenkirchner M; Meusser S; Paimela L; Rau R; Zeidler H; Leirisalo-Repo M; Peldan K
    Ann Rheum Dis; 1999 Apr; 58(4):220-5. PubMed ID: 10364900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
    Grindulis KA; McConkey B
    Scand J Rheumatol; 1985; 14(3):265-70. PubMed ID: 2864741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.
    Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I
    Ann Rheum Dis; 2007 Feb; 66(2):235-41. PubMed ID: 16926184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.